THE D5 DOPAMINE-RECEPTOR GENE IN SCHIZOPHRENIA - IDENTIFICATION OF A NONSENSE CHANGE AND MULTIPLE MISSENSE CHANGES BUT LACK OF ASSOCIATION WITH DISEASE
Jl. Sobell et al., THE D5 DOPAMINE-RECEPTOR GENE IN SCHIZOPHRENIA - IDENTIFICATION OF A NONSENSE CHANGE AND MULTIPLE MISSENSE CHANGES BUT LACK OF ASSOCIATION WITH DISEASE, Human molecular genetics, 4(4), 1995, pp. 507-514
To determine whether mutations in the D5 dopamine receptor gene (DRD5)
are associated with schizophrenia, the gene was examined in 78 unrela
ted schizophrenic individuals (156 DRD5 alleles). After amplification
by the polymerase chain reaction, products were examined by dideoxy fi
ngerprinting (ddF), a screening method related to single strand confor
mational polymorphism analysis that detects essentially 100% of mutati
ons. All samples with abnormal ddF patterns were sequenced. Nine diffe
rent sequence changes were identified. Five of these were sequence cha
nges that would result in protein alterations; of these, one was a non
sense change (C335X), one was a missense change in an amino acid conse
rved in all dopamine receptors (N351D), two were missense changes in a
mino acids that are identical in only some dopamine receptors and in o
nly some species (A269V; S453C), and one was a missense change in a no
n-conserved amino acid (P330Q). To investigate whether the nonsense ch
ange (C335X), predicted to prematurely truncate the receptor protein a
nd result in a 50% diminution of functional protein, was associated wi
th schizophrenia, other neuropsychiatric diseases, or specific neurops
ychological, psychophysiological, or personality traits, both case-con
trol and family analyses were performed. No statistically-significant
associations were detected with schizophrenia or other neuropsychiatri
c diseases. There also were no significant associations between any on
e measure of neuropsychological function. However, a post-hoc analysis
of combined measures of frontal lobe function hinted that heterozygot
es for C335X may have a vulnerability to mild impairment, but these fi
ndings must be interpreted with caution. In additional case-control an
alyses, none of the other three missense changes that occurred in evol
utionarily conserved amino acids (A269V, N351D, S453C) was found to be
associated with schizophrenia.